Canada Life’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.1M Buy
253,932
+2,277
+0.9% +$795K 0.14% 127
2025
Q4
$85.1M Sell
251,655
-38,466
-13% -$13.1M 0.15% 123
2025
Q3
$89.4M Buy
290,121
+8,872
+3% +$2.61M 0.13% 142
2025
Q2
$84.5M Sell
281,249
-39,000
-12% -$11.2M 0.13% 138
2025
Q1
$89.2M Buy
320,249
+9,596
+3% +$2.41M 0.16% 121
2024
Q4
$69.8M Sell
310,653
-13,550
-4% -$3.19M 0.12% 148
2024
Q3
$73.1M Buy
324,203
+3,074
+1% +$714K 0.13% 148
2024
Q2
$72.4M Buy
321,129
+36,686
+13% +$8.5M 0.14% 139
2024
Q1
$69.2M Sell
284,443
-3,441
-1% -$791K 0.14% 141
2023
Q4
$58.8M Sell
287,884
-48,019
-14% -$9.37M 0.13% 156
2023
Q3
$60.5M Buy
335,903
+8,913
+3% +$1.65M 0.15% 137
2023
Q2
$63.3M Sell
326,990
-24,910
-7% -$4.31M 0.15% 131
2023
Q1
$56.4M Buy
351,900
+11,899
+3% +$1.89M 0.14% 148
2022
Q4
$56.7M Sell
340,001
-8,755
-3% -$1.38M 0.15% 145
2022
Q3
$47.1M Buy
348,756
+1,096
+0.3% +$157K 0.13% 153
2022
Q2
$49.2M Sell
347,660
-45,540
-12% -$6.97M 0.13% 162
2022
Q1
$63.2M Buy
393,200
+3,585
+0.9% +$507K 0.13% 162
2021
Q4
$51.8M Buy
389,615
+59,297
+18% +$7.29M 0.11% 199
2021
Q3
$39.7M Sell
330,318
-85,603
-21% -$10.3M 0.09% 235
2021
Q2
$47.6M Sell
415,921
-8,844
-2% -$1.04M 0.11% 205
2021
Q1
$49.9M Sell
424,765
-286,419
-40% -$31M 0.12% 177
2020
Q4
$69.5M Sell
711,184
-103,066
-13% -$10.3M 0.13% 171
2020
Q3
$79M Buy
814,250
+31,982
+4% +$3.18M 0.17% 133
2020
Q2
$78.6M Buy
782,268
+229,546
+42% +$21.1M 0.18% 130
2020
Q1
$49.2M Sell
552,722
-11,428
-2% -$1.01M 0.13% 166
2019
Q4
$47.6M Buy
564,150
+146,597
+35% +$12.6M 0.1% 216
2019
Q3
$34.5M Buy
417,553
+138,339
+50% +$11.9M 0.08% 261
2019
Q2
$24.3M Sell
279,214
-5,529
-2% -$437K 0.06% 344
2019
Q1
$22.6M Buy
284,743
+19,117
+7% +$1.54M 0.06% 300
2018
Q4
$19.4M Buy
265,626
+30,749
+13% +$2.65M 0.06% 311
2018
Q3
$21.7M Sell
234,877
-17
-0% -$1.47K 0.05% 330
2018
Q2
$20.1M Sell
234,894
-2,492
-1% -$219K 0.05% 351
2018
Q1
$20.5M Buy
237,386
+103,514
+77% +$9.94M 0.05% 341
2017
Q4
$12.3M Sell
133,872
-292,165
-69% -$24.2M 0.03% 468
2017
Q3
$34.6M Buy
426,037
+49,664
+13% +$4.21M 0.09% 237
2017
Q2
$35.5M Buy
376,373
+231,504
+160% +$20.6M 0.09% 232
2017
Q1
$12.8M Sell
144,869
-9,914
-6% -$871K 0.03% 433
2016
Q4
$12.1M Sell
154,783
-276,303
-64% -$21.6M 0.03% 438
2016
Q3
$34.8M Buy
431,086
+11,892
+3% +$1.02M 0.1% 209
2016
Q2
$33.2M Buy
419,194
+149,849
+56% +$12M 0.1% 217
2016
Q1
$23.3M Buy
269,345
+13,499
+5% +$1.2M 0.08% 240
2015
Q4
$26.6M Sell
255,846
-7,288
-3% -$716K 0.1% 219
2015
Q3
$25M Buy
263,134
+28,402
+12% +$2.98M 0.1% 221
2015
Q2
$24.9M Sell
234,732
-38,907
-14% -$4.38M 0.09% 254
2015
Q1
$31M Buy
273,639
+53,812
+24% +$5.41M 0.11% 225
2014
Q4
$19.8M Sell
219,827
-47,609
-18% -$4.08M 0.07% 299
2014
Q3
$20.7M Buy
267,436
+50,797
+23% +$3.86M 0.07% 293
2014
Q2
$15.7M Buy
216,639
+56,956
+36% +$3.9M 0.05% 346
2014
Q1
$10.4M Buy
159,683
+8,161
+5% +$555K 0.04% 404
2013
Q4
$10.7M Buy
151,522
+16,461
+12% +$1.11M 0.04% 404
2013
Q3
$8.23M Buy
135,061
+134,123
+14,299% +$7.84M 0.03% 430
2013
Q2
$52K Buy
+938
New +$50.9K ﹤0.01% 677

Other funds holding COR

Canada Life's COR Position: Q1 2026 in Review

Canada Life increased its Cencora (COR) stake by 0.9% in Q1 2026, buying an estimated $795K and bringing the position to 253,932 shares worth $80.1M. The position accounts for 0.14% of the portfolio, ranked #127.

Canada Life first reported a position in COR in Q2 2013 and has held it in 52 quarters since. The position peaked at $89.4M in Q3 2025. 1,426 funds tracked by Wall St. Rank hold COR as of Q1 2026.

  • Canada Life held 253,932 shares of Cencora worth $80.1M as of Q1 2026.
  • Canada Life bought 2,277 Cencora shares in Q1 2026, an estimated $795K.
  • Cencora made up 0.14% of Canada Life's portfolio in Q1 2026, its #127 holding.
  • Canada Life first reported a position in Cencora in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Cencora position peaked at $89.4M in Q3 2025.
  • 1,426 funds tracked by Wall St. Rank held Cencora as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.